Page last updated: 2024-10-15

dihydrofolate

Description

dihydrofolic acid : A folic acid derivative acted upon by dihydrofolate reductase to produce tetrahydrofolic acid. It interacts with bacteria during cell division and is targeted by various drugs to prevent nucleic acid synthesis. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID135398604
CHEMBL ID46294
CHEBI ID15633
SCHEMBL ID8282
SCHEMBL ID16938288
MeSH IDM0056823

Synonyms (49)

Synonym
CHEBI:15633 ,
n-(7,8-dihydropteroyl)-l-glutamic acid
n-(4-{[(2-amino-4-oxo-3,4,7,8-tetrahydropteridin-6-yl)methyl]amino}benzoyl)-l-glutamic acid
(2s)-2-[[4-[(2-amino-4-oxo-7,8-dihydro-1h-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
l-glutamic acid, n-(4-(((2-amino-1,4,7,8-tetrahydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-
7,8-dihydro-l-folic acid
7,8-dihydropteroyl-l-glutamic acid
7,8-dihydropteroylglutamate
DIHYDROFOLATE ,
dihydrofolic acid
7,8-dihydrofolic acid
4033-27-6
C00415
nsc-165989
dihydrofolic acid, >=90%
DB02015
SMP1_000099
CHEMBL46294 ,
nsc 165989
kxp0knm559 ,
unii-kxp0knm559
bdbm18044
(2s)-2-[(4-{[(2-amino-4-oxo-1,4,7,8-tetrahydropteridin-6-yl)methyl]amino}phenyl)formamido]pentanedioic acid
(s)-2-{4-[(2-amino-4-hydroxy-7,8-dihydro-pteridin-6-ylmethyl)-amino]-benzoylamino}-pentanedioic acid
SCHEMBL8282
dihydrofolicacid
l-glutamic acid, n-[4-[[(2-amino-3,4,7,8-tetrahydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-
l-glutamic acid, n-(4-(((2-amino-3,4,7,8-tetrahydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-
calcium folinate impurity g [ep impurity]
7,8-dihydrofolic acid [dsc]
(2s)-2-((4-(((2-amino-4-oxo-1,4,7,8-tetrahydropteridin-6-yl)methyl)amino)benzoyl)amino)pentanedioic acid
SCHEMBL16938288
mfcd00083619
(2s)-2-[(4-{[(2-amino-4-oxo-3,4,7,8-tetrahydropteridin-6-yl)methyl]amino}phenyl)formamido]pentanedioic acid
bdbm50482590
n-[4-[[(2-amino-3,4,7,8-tetrahydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-l-glutamic acid
n-[4-[[(2-amino-1,4,7,8-tetrahydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-l-glutamic acid
n-(4-(((2-amino-1,4,7,8-tetrahydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-l-glutamic acid
l-n-[p-[[(2-amino-7,8-dihydro-4-hydroxy-6-pteridinyl)methyl]amino]benzoyl]-glutamic acid
n-[(4-{[(2-amino-4-oxo-1,4,7,8-tetrahydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-l-glutamic acid
(s)-2-(4-((2-amino-4-oxo-1,4,7,8-tetrahydropteridin-6-yl)methylamino)benzamido)pentanedioic acid
Q192367
HY-113267
CS-0059467
F82235
(2s)-2-[[4-[(2-amino-4-oxo-7,8-dihydro-3h-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
DTXSID401027140
(s)-2-(4-(((2-amino-4-oxo-3,4,7,8-tetrahydropteridin-6-yl)methyl)amino)benzamido)pentanedioic acid
AKOS040741641

Bioavailability

ExcerptReference
" Here, we present evidence that TMECG markedly reduces melanoma H(4)B and NO bioavailability and that TMECG action is abolished by the eNOS inhibitor N(omega)-nitro-L-arginine methyl ester or the H(2)O(2) scavenger catalase, which strongly suggests H(2)O(2)-dependent DHFR downregulation."( Mechanism of dihydrofolate reductase downregulation in melanoma by 3-O-(3,4,5-trimethoxybenzoyl)-(-)-epicatechin.
Cabezas-Herrera, J; Chazarra, S; Montenegro, MF; Rodríguez-López, JN; Sánchez-del-Campo, L, 2010
)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
Escherichia coli metaboliteAny bacterial metabolite produced during a metabolic reaction in Escherichia coli.
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
dihydrofolic acidsA group of heterocyclic compounds based on the 7,8-dihydropteroic acid skeleton conjugated with one or more L-glutamic acid units.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (25)

PathwayProteinsCompounds
superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis1034
superpathway of pyrimidine deoxyribonucleoside salvage619
pyrimidine deoxyribonucleosides salvage615
pyrimidine deoxyribonucleotides de novo biosynthesis II017
superpathway of tetrahydrofolate biosynthesis1029
tetrahydrofolate biosynthesis313
pyrimidine deoxyribonucleotides de novo biosynthesis I520
tetrahydrofolate biosynthesis II1232
tetrahydrofolate biosynthesis I013
Folate metabolism ( Folate metabolism )2039
Pyrimidine Nucleotides and Nucleosides metabolism ( Pyrimidine Nucleotides and Nucleosides metabolism )4549
Renz2020 - GEM of Human alveolar macrophage with SARS-CoV-20490
dTMP de novo biosynthesis (mitochondrial)010
pyrimidine deoxyribonucleotides biosynthesis from CTP016
folate metabolism022
purine and pyrimidine metabolism032
tetrahydrofolate biosynthesis I028
formylTHF biosynthesis II027
formylTHF biosynthesis I026
Folate biosynthesis08
Trans-sulfuration and one-carbon metabolism020
Fluoropyrimidine activity015
Folate metabolism156
Trans-sulfuration, one-carbon metabolism and related pathways053
Biochemical pathways: part I0466
Ethanol effects on histone modifications017
Disorders of folate metabolism and transport1827

Protein Targets (3)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Dihydrofolate synthase/folylpolyglutamate synthaseEscherichia coli K-12Ki3.10003.10003.10003.1000AID500671
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Dihydrofolate reductaseEscherichia coli K-12Kd2.36130.00001.24596.6000AID57251; AID57253; AID57256; AID57258; AID57262; AID57264; AID57266; AID57267; AID57268; AID57269
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Dihydrofolate reductaseLacticaseibacillus caseiKm0.36000.36000.36000.3600AID1147653
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (12)

Processvia Protein(s)Taxonomy
dihydrofolate biosynthetic processDihydrofolate synthase/folylpolyglutamate synthaseEscherichia coli K-12
10-formyltetrahydrofolate biosynthetic processDihydrofolate synthase/folylpolyglutamate synthaseEscherichia coli K-12
folic acid biosynthetic processDihydrofolate synthase/folylpolyglutamate synthaseEscherichia coli K-12
tetrahydrofolylpolyglutamate biosynthetic processDihydrofolate synthase/folylpolyglutamate synthaseEscherichia coli K-12
one-carbon metabolic processDihydrofolate synthase/folylpolyglutamate synthaseEscherichia coli K-12
folic acid-containing compound biosynthetic processDihydrofolate synthase/folylpolyglutamate synthaseEscherichia coli K-12
tetrahydrofolate biosynthetic processDihydrofolate synthase/folylpolyglutamate synthaseEscherichia coli K-12
folic acid biosynthetic processDihydrofolate synthase/folylpolyglutamate synthaseEscherichia coli K-12
tetrahydrofolylpolyglutamate biosynthetic processDihydrofolate synthase/folylpolyglutamate synthaseEscherichia coli K-12
10-formyltetrahydrofolate biosynthetic processDihydrofolate reductaseEscherichia coli K-12
response to xenobiotic stimulusDihydrofolate reductaseEscherichia coli K-12
folic acid biosynthetic processDihydrofolate reductaseEscherichia coli K-12
one-carbon metabolic processDihydrofolate reductaseEscherichia coli K-12
response to methotrexateDihydrofolate reductaseEscherichia coli K-12
tetrahydrofolate biosynthetic processDihydrofolate reductaseEscherichia coli K-12
response to antibioticDihydrofolate reductaseEscherichia coli K-12
dihydrofolate metabolic processDihydrofolate reductaseEscherichia coli K-12
folic acid metabolic processDihydrofolate reductaseEscherichia coli K-12
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (16)

Processvia Protein(s)Taxonomy
tetrahydrofolylpolyglutamate synthase activityDihydrofolate synthase/folylpolyglutamate synthaseEscherichia coli K-12
ATP bindingDihydrofolate synthase/folylpolyglutamate synthaseEscherichia coli K-12
dihydrofolate synthase activityDihydrofolate synthase/folylpolyglutamate synthaseEscherichia coli K-12
ligase activityDihydrofolate synthase/folylpolyglutamate synthaseEscherichia coli K-12
acid-amino acid ligase activityDihydrofolate synthase/folylpolyglutamate synthaseEscherichia coli K-12
metal ion bindingDihydrofolate synthase/folylpolyglutamate synthaseEscherichia coli K-12
guanosine tetraphosphate bindingDihydrofolate synthase/folylpolyglutamate synthaseEscherichia coli K-12
dihydrofolate reductase activityDihydrofolate reductaseEscherichia coli K-12
protein bindingDihydrofolate reductaseEscherichia coli K-12
folic acid bindingDihydrofolate reductaseEscherichia coli K-12
oxidoreductase activityDihydrofolate reductaseEscherichia coli K-12
NADP bindingDihydrofolate reductaseEscherichia coli K-12
methotrexate bindingDihydrofolate reductaseEscherichia coli K-12
dihydrofolic acid bindingDihydrofolate reductaseEscherichia coli K-12
NADP+ bindingDihydrofolate reductaseEscherichia coli K-12
NADPH bindingDihydrofolate reductaseEscherichia coli K-12
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (2)

Processvia Protein(s)Taxonomy
cytoplasmDihydrofolate synthase/folylpolyglutamate synthaseEscherichia coli K-12
cytoplasmDihydrofolate synthase/folylpolyglutamate synthaseEscherichia coli K-12
cytosolDihydrofolate reductaseEscherichia coli K-12
cytosolDihydrofolate reductaseEscherichia coli K-12
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (32)

Assay IDTitleYearJournalArticle
AID500670Inhibition of Escherichia coli K-12 recombinant His-tagged folylpoly-gamma-glutamate synthetase expressed in Escherichia coli BL21 at 200 uM LC-MS/MS method2008Nature chemical biology, Oct, Volume: 4, Issue:10
A domino effect in antifolate drug action in Escherichia coli.
AID57087Dissociation rate constant of compound for mutant T46S Escherichia coli dihydrofolate reductase1992Journal of medicinal chemistry, Jul-24, Volume: 35, Issue:15
Probing the molecular basis of resistance to pyrimethamine by site-directed mutagenesis.
AID58118Thermodynamic dissociation constant of compound for mutant S108 N Plasmodium falciparum dihydrofolate reductase; ND=no data1992Journal of medicinal chemistry, Jul-24, Volume: 35, Issue:15
Probing the molecular basis of resistance to pyrimethamine by site-directed mutagenesis.
AID91440Inhibitory activity against HIV-1 integrase at 200 uM2000Journal of medicinal chemistry, Jun-01, Volume: 43, Issue:11
Developing a dynamic pharmacophore model for HIV-1 integrase.
AID57251Thermodynamic Dissociation Constant for compound-Phe31-dihydrofolate reductase (DHFR) complex at pH 71988Journal of medicinal chemistry, Jan, Volume: 31, Issue:1
Evaluation of the importance of hydrophobic interactions in drug binding to dihydrofolate reductase.
AID89920Dissociation constant towards DHFR mutant F31W1996Journal of medicinal chemistry, Apr-26, Volume: 39, Issue:9
Methotrexate resistance of mouse dihydrofolate reductase: effect of substitution of phenylalanine-31 by serine or tryptophan.
AID57262Thermodynamic Dissociation Constant for compound-Val31-dihydrofolate reductase (DHFR) complex at pH 71988Journal of medicinal chemistry, Jan, Volume: 31, Issue:1
Evaluation of the importance of hydrophobic interactions in drug binding to dihydrofolate reductase.
AID57258Thermodynamic Dissociation Constant for compound-Tyr31-dihydrofolate reductase (DHFR) complex at pH 8.51988Journal of medicinal chemistry, Jan, Volume: 31, Issue:1
Evaluation of the importance of hydrophobic interactions in drug binding to dihydrofolate reductase.
AID134197Dissociation constant towards mouse wild type DHFR1996Journal of medicinal chemistry, Apr-26, Volume: 39, Issue:9
Methotrexate resistance of mouse dihydrofolate reductase: effect of substitution of phenylalanine-31 by serine or tryptophan.
AID57266Thermodynamic dissociation constant of compound for mutant T46A Escherichia coli dihydrofolate reductase1992Journal of medicinal chemistry, Jul-24, Volume: 35, Issue:15
Probing the molecular basis of resistance to pyrimethamine by site-directed mutagenesis.
AID57256Thermodynamic Dissociation Constant for compound-Tyr31-dihydrofolate reductase (DHFR) complex at pH 71988Journal of medicinal chemistry, Jan, Volume: 31, Issue:1
Evaluation of the importance of hydrophobic interactions in drug binding to dihydrofolate reductase.
AID57267Thermodynamic dissociation constant of compound for mutant T46N Escherichia coli dihydrofolate reductase1992Journal of medicinal chemistry, Jul-24, Volume: 35, Issue:15
Probing the molecular basis of resistance to pyrimethamine by site-directed mutagenesis.
AID1147634Inhibition of Lactobacillus casei thymidylate synthetase using dl-5,10-Methylene tetrahydropteroyl-L-glutamate as substrate at 1 x 10'-4 M by spectrophotometric analysis1977Journal of medicinal chemistry, Nov, Volume: 20, Issue:11
Diastereoisomers of 5,10-methylene-5,6,7,8-tetrahydropteroyl-D-glutamic acid.
AID1147640Inhibition of Lactobacillus casei thymidylate synthetase using dl-5,10-Methylene tetrahydropteroyl-L-glutamate as substrate at 1 x 10'-4 M relative to control1977Journal of medicinal chemistry, Nov, Volume: 20, Issue:11
Diastereoisomers of 5,10-methylene-5,6,7,8-tetrahydropteroyl-D-glutamic acid.
AID500671Inhibition of Escherichia coli K-12 recombinant His-tagged folylpoly-gamma-glutamate synthetase expressed in Escherichia coli BL21 LC-MS/MS method2008Nature chemical biology, Oct, Volume: 4, Issue:10
A domino effect in antifolate drug action in Escherichia coli.
AID134195Dissociation constant towards mouse DHFR mutant hF31S1996Journal of medicinal chemistry, Apr-26, Volume: 39, Issue:9
Methotrexate resistance of mouse dihydrofolate reductase: effect of substitution of phenylalanine-31 by serine or tryptophan.
AID57264Thermodynamic Dissociation Constant for compound-Val31-dihydrofolate reductase (DHFR) complex at pH 8.51988Journal of medicinal chemistry, Jan, Volume: 31, Issue:1
Evaluation of the importance of hydrophobic interactions in drug binding to dihydrofolate reductase.
AID57086Dissociation rate constant of compound for mutant T46N Escherichia coli dihydrofolate reductase1992Journal of medicinal chemistry, Jul-24, Volume: 35, Issue:15
Probing the molecular basis of resistance to pyrimethamine by site-directed mutagenesis.
AID227965Dissociation constant towards wild type DHFR1996Journal of medicinal chemistry, Apr-26, Volume: 39, Issue:9
Methotrexate resistance of mouse dihydrofolate reductase: effect of substitution of phenylalanine-31 by serine or tryptophan.
AID1147642Activity of Lactobacillus casei dihydrofolate reductase at 5 x 10'-5 M by spectrophotometric analysis1977Journal of medicinal chemistry, Nov, Volume: 20, Issue:11
Diastereoisomers of 5,10-methylene-5,6,7,8-tetrahydropteroyl-D-glutamic acid.
AID89922Dissociation constant towards human DHFR mutant hF31S1996Journal of medicinal chemistry, Apr-26, Volume: 39, Issue:9
Methotrexate resistance of mouse dihydrofolate reductase: effect of substitution of phenylalanine-31 by serine or tryptophan.
AID227964Dissociation constant towards DHFR mutant hF31S; no data1996Journal of medicinal chemistry, Apr-26, Volume: 39, Issue:9
Methotrexate resistance of mouse dihydrofolate reductase: effect of substitution of phenylalanine-31 by serine or tryptophan.
AID57085Dissociation rate constant of compound for mutant T46A Escherichia coli dihydrofolate reductase1992Journal of medicinal chemistry, Jul-24, Volume: 35, Issue:15
Probing the molecular basis of resistance to pyrimethamine by site-directed mutagenesis.
AID57088Dissociation rate constant of compound for wild type Escherichia coli dihydrofolate reductase1992Journal of medicinal chemistry, Jul-24, Volume: 35, Issue:15
Probing the molecular basis of resistance to pyrimethamine by site-directed mutagenesis.
AID91439Inhibitory activity against HIV-1 integrase at 1 mM2000Journal of medicinal chemistry, Jun-01, Volume: 43, Issue:11
Developing a dynamic pharmacophore model for HIV-1 integrase.
AID57269Thermodynamic dissociation constant of compound for wild type Escherichia coli dihydrofolate reductase1992Journal of medicinal chemistry, Jul-24, Volume: 35, Issue:15
Probing the molecular basis of resistance to pyrimethamine by site-directed mutagenesis.
AID57253Thermodynamic Dissociation Constant for compound-Phe31-dihydrofolate reductase (DHFR) complex at pH 8.51988Journal of medicinal chemistry, Jan, Volume: 31, Issue:1
Evaluation of the importance of hydrophobic interactions in drug binding to dihydrofolate reductase.
AID89924Dissociation constant towards human wild type DHFR1996Journal of medicinal chemistry, Apr-26, Volume: 39, Issue:9
Methotrexate resistance of mouse dihydrofolate reductase: effect of substitution of phenylalanine-31 by serine or tryptophan.
AID91559Inhibitory activity against HIV-1 integrase at 25 uM2000Journal of medicinal chemistry, Jun-01, Volume: 43, Issue:11
Developing a dynamic pharmacophore model for HIV-1 integrase.
AID57268Thermodynamic dissociation constant of compound for mutant T46S Escherichia coli dihydrofolate reductase1992Journal of medicinal chemistry, Jul-24, Volume: 35, Issue:15
Probing the molecular basis of resistance to pyrimethamine by site-directed mutagenesis.
AID1147653Activity of Lactobacillus casei NCB 6375 dihydrofolate reductase by fluorimetric analysis1977Journal of medicinal chemistry, Nov, Volume: 20, Issue:11
Diastereoisomers of 5,10-methylene-5,6,7,8-tetrahydropteroyl-D-glutamic acid.
AID58120Thermodynamic dissociation constant of compound for Plasmodium falciparum dihydrofolate reductase; ND=no data1992Journal of medicinal chemistry, Jul-24, Volume: 35, Issue:15
Probing the molecular basis of resistance to pyrimethamine by site-directed mutagenesis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (170)

TimeframeStudies, This Drug (%)All Drugs %
pre-199055 (32.35)18.7374
1990's50 (29.41)18.2507
2000's47 (27.65)29.6817
2010's17 (10.00)24.3611
2020's1 (0.59)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews7 (4.02%)6.00%
Case Studies2 (1.15%)4.05%
Observational0 (0.00%)0.25%
Other165 (94.83%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]